Abstract| Volume 12, ISSUE 7, SUPPLEMENT , S79, August 2016

A prospective, international, multi-center, non-randomized, open label study (HERO) of health outcomes and the rates of explants and reoperations after 5 years of treatment with laparoscopic adjustable gastric banding

      In the15 years that laparoscopic adjustable gastric banding (LAGB) has been approved in the U.S. there have been advances in the technology, surgical technique, and aftercare that have led to clear improvements in health outcomes and reductions in explants and reoperations.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect